Positron Emission Tomography in Oncology: A Review
Authors:
- K.A. WoodKWK.A. Wood
- P.J. HoskinPHP.J. Hoskin
- M.I. SaundersMSM.I. Saunders
- 1 May 2007
- journal article
- review article
- Published by Elsevier in Clinical Oncology
- Vol. 19 (4) , 237-255
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- The Role of Fluorodeoxyglucose, 18F-Dihydroxyphenylalanine, 18F-Choline, and 18F-Fluoride in Bone Imaging with Emphasis on Prostate and BreastSeminars in Nuclear Medicine, 2006
- Prognostic Significance of Preoperative [18-F] Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) Imaging in Patients With Resectable Soft Tissue SarcomasAnnals of Surgery, 2005
- Positron Emission Tomography in Limited-Stage Small-Cell Lung Cancer: A Prospective StudyJournal of Clinical Oncology, 2004
- The utility of 2-deoxy-2-6F9fluoro-D-glucose-positron emission tomography and combined positron emission tomography and computed tomography in lymphoma and melanomaMolecular Imaging and Biology, 2004
- Clinical Use of Fluorodeoxyglucose F 18 Positron Emission Tomography for Detection of Renal Cell CarcinomaJournal of Urology, 2004
- Expression of GLUT‐1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F‐18]‐fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovaryInternational Journal of Cancer, 2004
- FDG-PET-Detected Extracranial Metastasis in Patients with Non-Small Cell Lung Cancer Undergoing Staging for Surgery or Radical RadiotherapyActa Oncologica, 2003
- CLINICAL ROLE OF F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR DETECTION AND MANAGEMENT OF RENAL CELL CARCINOMAJournal of Urology, 2001
- Staging Hodgkin's Disease with 18-FDG PET Comparison with CT and SurgeryClinical Positron Imaging, 1998
- 18-fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant gliomaCancer, 1997